Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | FABP4 | P15090 | 3/20 | 0.50 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | F7 | P08709 | 3/20 | 0.50 |
| ▸ | F3 | P13726 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.50 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1302231 | 1.00 | HSD17B10 (0.50) | HSD17B10FABP4TERTF7F3 | |
| SCHEMBL592267 | 1.00 | HSD17B10 (0.50) | HSD17B10FABP4TERTF7F3 | |
| SCHEMBL1301683 | 1.00 | HSD17B10 (0.50) | HSD17B10FABP4TERTF7F3 | |
| SCHEMBL1300936 | 1.00 | HSD17B10 (0.50) | HSD17B10FABP4TERTF7F3 | |
| SCHEMBL19411396 | 1.00 | HSD17B10 (0.50) | HSD17B10FABP4TERTF7F3 | |
| SCHEMBL25407500 | 1.00 | HSD17B10 (0.50) | HSD17B10FABP4TERTF7F3 | |
| SCHEMBL593168 | 1.00 | HSD17B10 (0.50) | HSD17B10FABP4TERTF7F3 | |
| SCHEMBL20503632 | 1.00 | HSD17B10 (0.50) | HSD17B10FABP4TERTF7F3 | |
| SCHEMBL20636558 | 1.00 | HSD17B10 (0.50) | HSD17B10FABP4TERTF7F3 | |
| SCHEMBL1302228 | 1.00 | HSD17B10 (0.50) | HSD17B10FABP4TERTF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719056-A1 | MICROENCAPSULATED PHEROMONE FORMULATIONS | FMC Agricultural Solutions A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| EP-4658793-A1 | A PROCESS FOR PRODUCING PHEROMONES AND APPLICATIONS THEREOF | ATGC Biotech Pvt Ltd (IN) | 2025-12-10 | — | — | EP | claimed |
| WO-2025046624-A1 | A METHOD FOR MATING DISRUPTION OF INSECTS PESTS USING SEMIOCHEMICALS | PHEROMONES BIOTECH LLP (IN) | 2025-03-06 | — | — | WO | claimed |
| WO-2024254039-A1 | MICROENCAPSULATED PHEROMONE FORMULATIONS | FMC Agricultural Solutions A/S (DK) | 2024-12-12 | — | — | WO | claimed |
| WO-2024161427-A1 | A PROCESS FOR PRODUCING PHEROMONES AND APPLICATIONS THEREOF | ATGC BIOTECH PVT LTD (IN) | 2024-08-08 | — | — | WO | claimed |
| WO-2016128239-A1 | PESTICIDAL MIXTURE COMPRISING A PYRAZOLE COMPOUND AND A BIOPESTICIDE | BASF SE (DE) | 2016-08-18 | — | — | WO | claimed |
| US-20060198857-A1 | Insect control system | CERTIS EUROPE B.V. (NL) | 2006-09-07 | — | — | US | claimed |
| EP-4719056-A1 | MICROENCAPSULATED PHEROMONE FORMULATIONS | FMC Agricultural Solutions A/S (DK) | 2026-04-08 | — | — | EP | disclosed |
| EP-4658793-A1 | A PROCESS FOR PRODUCING PHEROMONES AND APPLICATIONS THEREOF | ATGC Biotech Pvt Ltd (IN) | 2025-12-10 | — | — | EP | disclosed |
| WO-2025215576-A1 | A BAIT COMPOSITION | UPL LIMITED (IN) | 2025-10-16 | — | — | WO | disclosed |
| EP-3583088-B1 | SYNTHESIS OF PHEROMONES AND RELATED MATERIALS VIA OLEFIN METATHESIS | PROVIVI INC (US) | 2025-09-10 | — | — | EP | disclosed |
| EP-4157814-B1 | SYNTHESIS OF PHEROMONE DERIVATIVES VIA Z-SELECTIVE OLEFIN METATHESIS | PROVIVI INC (US) | 2025-08-06 | — | — | EP | disclosed |
| US-12344573-B2 | Synthesis of straight-chain lepidopteran pheromones through one- or two-carbon homologation of fatty alkenes | PROVIVI, INC. (US) | 2025-07-01 | — | — | US | disclosed |
| EP-1608223-A1 | INSECT CONTROL SYSTEM | Agrisense-BCS Limited (GB) | 2005-12-28 | — | — | EP | disclosed |
| US-20050063956-A1 | Method and device for attracting insects | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2005-03-24 | — | — | US | disclosed |
| WO-2005016385-A1 | INSECTICIDAL AND ACARICIDAL COMPOSITIONS WITH UV BLOCKERS AND PHEROMONES | SIRENE CALL PTY LTD (AU) | 2005-02-24 | — | — | WO | disclosed |
| WO-2004086866-A1 | INSECT CONTROL SYSTEM | AGRISENSE-BCS LIMITED (GB) | 2004-10-14 | — | — | WO | disclosed |
| EP-1229786-A1 | METHOD AND DEVICE FOR ATTRACTING INSECTS | COLORADO STATE UNIVERSITY (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001032013-A1 | METHOD AND DEVICE FOR ATTRACTING INSECTS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2001-05-10 | — | — | WO | disclosed |
| US-5707638-A | ANIMAL ATTRACTANTS AND KILLING FORMULATIONS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050063956-A1 | Method and device for attracting insects | ACHE, BCHE, CA3 | HSD17B10 2938/4885FABP4 3113/4885TERT 3220/4885 |
| US-12344573-B2 | Synthesis of straight-chain lepidopteran pheromones through one- or two-carbon homologation of fatty alkenes | COASY, FASN, CYP11A1 | HSD17B10 19/4885FABP4 325/4885TERT 2240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.